Targeting lysine demethylase 6B ameliorates ASXL1 truncation-mediated myeloid malignancies in preclinical models.
Ge G, Zhang P, Sui P, Chen S, Yang H, Guo Y, Rubalcava IP, Noor A, Delma CR, Agosto-Peña J, Geng H, Medina EA, Liang Y, Nimer SD, Mesa R, Abdel-Wahab O, Xu M, Yang FC.
Ge G, et al. Among authors: sui p.
J Clin Invest. 2024 Jan 2;134(1):e163964. doi: 10.1172/JCI163964.
J Clin Invest. 2024.
PMID: 37917239
Free PMC article.